Cover Image

The Drug manufacturing industry : a prescription for profits : staff report of the Special Committee on Aging, United States Senate.

Bibliographic Details
Corporate Authors:	ProQuest (Firm), United States. Congress. Senate. Special Committee on Aging
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O., 1991.
Series:	U.S. Congressional Research.
Subjects:	Pharmaceutical industry > Prices > United States. Prescription pricing > United States. Profit > United States. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

The politics of the international pricing of prescription drugs /
by: Harrison, Christopher Scott
Published: (2004)

Public attitudes toward prescription costs and the drug industry : a report /
Published: (1955)

Competition in prescription drug markets, 2017-2022 /
by: Parasrampuria, Sonal, et al.
Published: (2023)

Prescription drug advertising to consumers : staff report /
Published: (1984)

A Status report, accessibility and affordability of prescription drugs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate.
Published: (1992)

Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.
Published: (1986)

Measuring prescription drug prices : a primer on the CPI Prescription Drug Index /
Published: (2019)

The demand for prescription drugs as a function of cost-sharing /
by: Leibowitz, Arleen A.
Published: (1985)

A Status report : accessibility and affordability of prescription drugs for older Americans (annotated) : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate.
Published: (1992)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry.
Published: (1998)

Effects of using generic drugs on Medicare's prescription drug spending.
by: Somers, Julie
Published: (2010)

Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate.
Published: (1989)

Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Sixth Congress, first session, June 23, 1999.
Published: (1999)

Issues in designing a prescription drug benefit for Medicare.
Published: (2002)

Issues in designing a prescription drug benefit for Medicare.
Published: (2002)

Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007.
Published: (2007)

Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007.
Published: (2007)

Prescription drug prices : should the federal government regulate them? /
by: Guenther, Gary
Published: (1992)

Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session.
Published: (2019)

The top five outpatient prescription drugs ranked by total expense for children, adults, and the elderly, 2004 /
by: Stagnitti, Marie N.
Published: (2007)

Pay-for-delay : how drug company pay-offs cost consumers billions : an FTC staff study.
Published: (2010)

Reimbursement and access to prescription drugs under Medicare part B : hearing before the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Seventh Congress, second session, March 14, 2002.
Published: (2002)

Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019.
Published: (2021)

Prescription drugs : modernizing Medicare for the 21st century : hearing before ... 106th Congress, 2nd session, June 14, 2000.
Published: (2000)

Prescription drug price inflation : are prices rising too fast? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, December 8, 2009.
Published: (2012)

Coverage of outpatient prescription drugs under Medicare part B : hearings before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundredth Congress, first session, April 23 and June 2, 1987.
Published: (1988)

The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003.
Published: (2003)

The economic aspects of the pharmaceutical industry in the United States : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 25, 2003.
Published: (2003)

Manufactured crisis : how devastating drug price increases are harming America's seniors.
Published: (2018)

The role of pharmacy benefit managers in prescription drug markets : report prepared by the House Committee on Oversight and Accountability staff.
Published: (2024)

Pricing a new drug /
by: Munshaw, Supriya, et al.
Published: (2019)

Prescription drug affordability and innovation : addressing challenges in today's market : hearing before the Committee on Finance, United States Senate, One Hundred Fifteenth Congress, second session, June 26, 2018.
Published: (2020)

Response to Drug Industry Claims on Prescription Drug Price Differences Between the U.S. and Other Countries /
Published: (2002)

Guide to prescription drug costs /
Published: (1980)

Prescription Drug Sunshine, Transparency, Accountability and Reporting Act : report (to accompany H.R. 2113) (including cost estimate of the Congressional Budget Office).
Published: (2020)

Why does the U.S. pay the highest prices in the world for prescription drugs? : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, first session on examining why the U.S. pays the highest prices in the world for prescription drugs, March 23, 2021.
Published: (2022)

The complex web of prescription drug prices : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC.
Published: (2022)

Brand-name prescription drug pricing : lack of therapeutically equivalent drugs and limited competition may contribute to extraordinary price increases : report to congressionals requesters.
Published: (2009)

Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002.
Published: (2003)